Christensen, S F, Svingel, L S, Kjærsgaard, A, Stenling, A, Darvalics, B, Paulsson, B, Andersen, C L, Christiansen, C F, Stentoft, J, Starklint, J, Severinsen, M T, Clausen, M B, Hilsøe, M H, Hasselbalch, H C, Frederiksen, H, Mikkelsen, E M & Bak, M 2022, ' Healthcare resource utilization in patients with myeloproliferative neoplasms : A Danish nationwide matched cohort study ', European Journal of Haematology, vol. 109, no. 5, pp. 526-541 . https://doi.org/10.1111/ejh.13841 Christensen, S F, Svingel, L S, Kjærsgaard, A, Stenling, A, Darvalics, B, Paulsson, B, Andersen, C L, Christiansen, C F, Stentoft, J, Starklint, J, Severinsen, M T, Clausen, M B, Hilsøe, M H, Hasselbalch, H C, Frederiksen, H, Mikkelsen, E M & Bak, M 2022, ' Healthcare Resource Utilization in Patients with Myeloproliferative Neoplasms : A Danish Nationwide Matched Cohort Study ', European Journal of Haematology, vol. 109, no. 5, pp. 526-541 . https://doi.org/10.1111/ejh.13841 Christensen, S F, Svingel, L S, Kjaersgaard, A, Stenling, A, Darvalics, B, Paulsson, B, Andersen, C L, Christiansen, C F, Stentoft, J, Starklint, J, Severinsen, M T, Clausen, M B, Hilsoe, M H, Hasselbalch, H C, Frederiksen, H, Mikkelsen, E M & Bak, M 2022, ' Healthcare resource utilization in patients with myeloproliferative neoplasms : A Danish nationwide matched cohort study ', European Journal of Haematology, vol. 109, no. 5, pp. 526-541 . https://doi.org/10.1111/ejh.13841
Knudsen, T A, Skov, V, Stevenson, K E, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U, Frederiksen, M, Kristensen, T, Kruse, T, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses ', Blood Advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856 Knudsen, T A, Skov, V, Stevenson, K E, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic Profiling of a Randomized Trial of Interferon-α versus Hydroxyurea in MPN Reveals Mutation-Specific Responses ', Blood advances, vol. 6, no. 7, pp. 2107–2119 . https://doi.org/10.1182/bloodadvances.2021004856 Knudsen, T A, Skov, V, Stevenson, K, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, Fassi, D E, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses ', Blood advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856 Knudsen, T A, Skov, V, Stevenson, K, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, Fassi, D E, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses ', Blood Advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856
Flygt, H, Söderlund, S, Stentoft, J, Richter, J, Koskenvesa, P, Mustjoki, S, Majeed, W, Lübking, A, Dreimane, A, Markevärn, B, Stenke, L, Myhr Eriksson, K, Gjertsen, B T, Gedde-Dahl, T, Dimitrijevic, A, Udby, L, Olsson-Strömberg, U & Hjorth-Hansen, H 2021, ' Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP : Five-year follow-up of the NordCML007 study ', European Journal of Haematology, vol. 107, no. 6, pp. 617-623 . https://doi.org/10.1111/ejh.13699 Flygt, H, Söderlund, S, Stentoft, J, Richter, J, Koskenvesa, P, Mustjoki, S, Majeed, W, Lübking, A, Dreimane, A, Markevärn, B, Stenke, L, Myhr Eriksson, K, Gjertsen, B T, Gedde-Dahl, T, Dimitrijevic, A, Udby, L, Olsson-Strömberg, U & Hjorth-Hansen, H 2021, ' Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP : Five-year follow-up of the NordCML007 study ', European journal of haematology, vol. 107, no. 6, pp. 617-623 . https://doi.org/10.1111/ejh.13699